Skip to main content

Table 3 Interaction hazard risk analysis betwee HCQ and steroid dose group

From: Hydroxychloroquine dose-dependently reduces the risk of incident diabetes in primary Sjögren syndrome patients on glucocorticoids: a nationwide population-based cohort study

  1. All model were adjusted by disease, gender, age group and comorbidities.
  2. HCQ Hydroxychloroquine, cDDD  cumulative defined daily dose
Back to article page

Arthritis Research & Therapy

ISSN: 1478-6362

Contact us